Back to Search
Start Over
A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study.
- Source :
- Rheumatology, 44 (4
- Publication Year :
- 2005
-
Abstract
- To analyse the effect of a dose increase in patients with severe rheumatoid arthritis (RA) with insufficient clinical response to 3 mg/kg infliximab every 8 weeks.<br />Evaluation Studies<br />Journal Article<br />Multicenter Study<br />Research Support, Non-U.S. Gov't<br />SCOPUS: ar.j<br />info:eu-repo/semantics/published
Details
- Database :
- OAIster
- Journal :
- Rheumatology, 44 (4
- Notes :
- No full-text files, English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.ocn855623093
- Document Type :
- Electronic Resource